MYC and colorectal carcinoma: In CRC patients, it was reported that c-MYC amplification, defined as a c-MYC/CEP8 ratio > 2, was frequently detected by using fluorescent in situ hybridization (9.0–14.2%), but was unrelated to clinical outcome and pathological data [26].